Among the cytokines or cytokine/receptor pathways used in clinical trials for the treatment of metastatic melanoma we must mention IL-2, IL-8, IL-10, IL-12, IFN-α and TNF-α, as well as tumor growth factors. Here, IL2 is linked to metastatic melanoma.